Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Immatics N.V. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- +3 vs. Q2 2024
- Shares held
- 75.9M
- +143.7K (+0.2%) vs. Q2 2024
- Total value
- $865.8M
- −$14.1M (−1.6%) vs. Q2 2024
- New holders
- 16
- 18 more added
- Sold out
- 13
- 41 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $1.01B |
| Q1 2026 | 84 | $1.06B |
| Q4 2025 | 75 | $1.07B |
| Q3 2025 | 63 | $787.2M |
| Q2 2025 | 70 | $500.9M |
| Q1 2025 | 76 | $412.1M |
| Q4 2024 | 85 | $656.0M |
| Q3 2024 | 91 | $865.8M |
| Q2 2024 | 90 | $890.3M |
| Q1 2024 | 77 | $748.9M |
| Q4 2023 | 76 | $522.3M |
| Q3 2023 | 74 | $501.0M |
| Q2 2023 | 68 | $472.7M |
| Q1 2023 | 65 | $238.5M |
| Q4 2022 | 63 | $296.5M |
| Q3 2022 | 54 | $221.4M |
| Q2 2022 | 49 | $186.9M |
| Q1 2022 | 47 | $173.0M |
| Q4 2021 | 49 | $309.5M |
| Q3 2021 | 51 | $292.1M |
| Q2 2021 | 50 | $243.4M |
| Q1 2021 | 44 | $237.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Immatics N.V.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 87 | $0 | 0.00% | −1,457−94.4% | Reduced |
| Huntington National Bank | 1 | $11 | 0.00% | −700−99.9% | Reduced |
| American Capital Advisory, LLC | 6 | $69 | 0.00% | +6 | New |
| Wells Fargo & Company | 14 | $160 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 80 | $913 | 0.00% | 00.0% | Unchanged |
| Clear Street Markets LLC | 125 | $1.00K | 0.00% | +125 | New |
| GWM Advisors LLC | 104 | $1.19K | 0.00% | 00.0% | Unchanged |
| nVerses Capital, LLC | 200 | $2.28K | 0.00% | −800−80.0% | Reduced |
| US Bancorp | 204 | $2.33K | 0.00% | −233−53.3% | Reduced |
| Advisor Group Holdings, Inc. | 284 | $3.24K | 0.00% | −279−49.6% | Reduced |
| Bank of America Corp | 1,344 | $15.3K | 0.00% | −43,380−97.0% | Reduced |
| Citigroup Inc | 1,365 | $15.6K | 0.00% | −172−11.2% | Reduced |
| Barclays PLC | 1,434 | $16.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,606 | $41.1K | 0.00% | +3,606 | New |
| UBS Group AG | 4,751 | $54.2K | 0.00% | +989+26.3% | Added |
| Virtus ETF Advisers LLC | 7,115 | $81.2K | 0.04% | +125+1.8% | Added |
| Texas Capital Bank Wealth Management Services Inc | 10,000 | $114.1K | 0.01% | +10,000 | New |
| Quarry LP | 11,000 | $125.5K | 0.04% | +2,500+29.4% | Added |
| Forefront Analytics, LLC | 11,180 | $127.6K | 0.06% | −807−6.7% | Reduced |
| Engineers Gate Manager LP | 12,729 | $145.2K | 0.00% | −12,613−49.8% | Reduced |
| Exchange Traded Concepts, LLC | 13,155 | $150.1K | 0.00% | −4,956−27.4% | Reduced |
| Voloridge Investment Management, LLC | 13,516 | $154.2K | 0.00% | −59,786−81.6% | Reduced |
| Susquehanna International Group, LLP | 13,829 | $157.8K | 0.00% | +13,829 | New |
| XTX Topco Ltd | 14,116 | $161.1K | 0.01% | −13,471−48.8% | Reduced |
| Campbell & CO Investment Adviser LLC | 14,798 | $168.8K | 0.01% | +14,798 | New |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 18,224 | $207.9K | 0.00% | −1,720−8.6% | Reduced |
| Caption Management, LLC | 18,900 | $215.6K | 0.02% | +18,900 | New |
| Jane Street Group, LLC | 20,746 | $236.7K | 0.00% | −34,785−62.6% | Reduced |
| Algert Global LLC | 21,458 | $244.8K | 0.01% | +640+3.1% | Added |
| J. Goldman & Co LP | 22,788 | $260.0K | 0.01% | −6,750−22.9% | Reduced |
| Trexquant Investment LP | 23,721 | $270.7K | 0.00% | −31,287−56.9% | Reduced |
| Squarepoint Ops LLC | 24,282 | $277.1K | 0.00% | +24,282 | New |
| Pale Fire Capital SE | 24,462 | $279.1K | 0.04% | +12,938+112.3% | Added |
| AlphaCentric Advisors LLC | 25,000 | $285.3K | 0.21% | +5,000+25.0% | Added |
| Corton Capital Inc. | 25,439 | $290.3K | 0.14% | +4,100+19.2% | Added |
| Point72 Asset Management, L.P. | 26,100 | $297.8K | 0.00% | +26,100 | New |
| New York State Common Retirement Fund | 27,587 | $314.8K | 0.00% | −3,569−11.5% | Reduced |
| Mercer Global Advisors Inc | 29,877 | $334.9K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 33,600 | $383.4K | 0.01% | −15,391−31.4% | Reduced |
| Cubist Systematic Strategies, LLC | 35,394 | $403.8K | 0.01% | −171,526−82.9% | Reduced |
| Northern Trust Corp | 35,922 | $409.9K | 0.00% | −694−1.9% | Reduced |
| Tudor Investment Corp Et Al | 36,011 | $410.9K | 0.00% | −15,368−29.9% | Reduced |
| HighVista Strategies LLC | 45,544 | $519.7K | 0.18% | −32,277−41.5% | Reduced |
| Ikarian Capital, LLC | 49,415 | $563.8K | 0.18% | 00.0% | Unchanged |
| BIT Capital GmbH | 51,102 | $583.1K | 0.06% | +51,102 | New |
| Two Sigma Advisers, LP | 59,800 | $682.3K | 0.00% | −40,500−40.4% | Reduced |
| D. E. Shaw & Co., Inc. | 63,647 | $726.2K | 0.00% | +63,647 | New |
| Two Sigma Investments, LP | 106,669 | $1.22M | 0.00% | −24,330−18.6% | Reduced |
| Geode Capital Management, LLC | 110,007 | $1.26M | 0.00% | −210−0.2% | Reduced |
| Goldman Sachs Group Inc | 114,265 | $1.30M | 0.00% | −1,638,090−93.5% | Reduced |
| Crestline Management, LP | 136,721 | $1.56M | 0.09% | +10,396+8.2% | Added |
| DAFNA Capital Management LLC | 145,000 | $1.65M | 0.39% | 00.0% | Unchanged |
| Morgan Stanley | 163,571 | $1.87M | 0.00% | −160,870−49.6% | Reduced |
| Manufacturers Life Insurance Company, The | 164,766 | $1.88M | 0.00% | +13,997+9.3% | Added |
| Samsara BioCapital, LLC | 198,000 | $2.26M | 0.43% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 203,614 | $2.32M | 0.11% | 00.0% | Unchanged |
| Colony Group, LLC | 215,449 | $2.46M | 0.01% | +215,449 | New |
| State Street Corp | 225,202 | $2.57M | 0.00% | +22,710+11.2% | Added |
| Standard Life Aberdeen plc | 232,900 | $2.66M | 0.00% | +232,900 | New |
| Affinity Asset Advisors, LLC | 250,000 | $2.85M | 0.44% | −50,000−16.7% | Reduced |
| Zimmer Partners, LP | 280,000 | $3.19M | 0.06% | −80,000−22.2% | Reduced |
| Walleye Capital LLC | 282,193 | $3.22M | 0.03% | −137,200−32.7% | Reduced |
| Schroder Investment Management Group | 280,447 | $3.29M | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 299,066 | $3.41M | 0.00% | −22,694−7.1% | Reduced |
| Aquilo Capital Management, LLC | 333,502 | $3.81M | 4.28% | +133,502+66.8% | Added |
| TD Asset Management Inc | 359,244 | $4.21M | 0.00% | +1,718+0.5% | Added |
| Sofinnova Investments, Inc. | 386,100 | $4.41M | 0.36% | −410,604−51.5% | Reduced |
| StemPoint Capital LP | 449,735 | $5.13M | 1.54% | −52,472−10.4% | Reduced |
| ExodusPoint Capital Management, LP | 451,476 | $5.15M | 0.05% | +451,476 | New |
| Nantahala Capital Management, LLC | 625,659 | $7.14M | 0.60% | −162,315−20.6% | Reduced |
| Artisan Partners Limited Partnership | 661,317 | $7.55M | 0.01% | −27,167−3.9% | Reduced |
| University of Texas/Texas Am Investment Managment Co | 697,431 | $7.96M | 1.29% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 700,000 | $7.99M | 0.81% | −115,000−14.1% | Reduced |
| BlackRock, Inc. | 703,655 | $8.03M | 0.00% | +703,655 | New |
| Sphera Funds Management Ltd. | 721,111 | $8.23M | 1.35% | −10,000−1.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 721,252 | $8.23M | 0.01% | −30,000−4.0% | Reduced |
| Wasatch Advisors Inc | 872,511 | $9.96M | 0.05% | +29,239+3.5% | Added |
| Frazier Life Sciences Management, L.P. | 1,354,711 | $15.5M | 0.62% | +202,255+17.5% | Added |
| Braidwell LP | 1,647,565 | $18.8M | 0.53% | +1,647,565 | New |
| Ra Capital Management, L.P. | 1,750,000 | $20.0M | 0.23% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,920,843 | $21.9M | 0.02% | +1,035,436+116.9% | Added |
| OrbiMed Advisors LLC | 2,006,381 | $22.9M | 0.42% | 00.0% | Unchanged |
| Woodline Partners LP | 2,501,962 | $28.5M | 0.24% | −760,048−23.3% | Reduced |
| Price T Rowe Associates Inc | 3,494,502 | $39.9M | 0.00% | −145,060−4.0% | Reduced |
| Vestal Point Capital, LP | 3,750,000 | $42.8M | 3.38% | +1,000,000+36.4% | Added |
| Paradigm Biocapital Advisors LP | 3,904,862 | $44.6M | 1.56% | +482,897+14.1% | Added |
| Baker Bros. Advisors LP | 6,443,398 | $73.5M | 0.76% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 7,379,636 | $84.2M | 0.05% | −54,071−0.7% | Reduced |
| Perceptive Advisors LLC | 8,086,159 | $92.3M | 1.98% | 00.0% | Unchanged |
| Wellington Management Group LLP | 9,681,183 | $110.5M | 0.02% | +144,549+1.5% | Added |
| RTW Investments, LP | 10,000,000 | $114.1M | 1.65% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −946,563−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −417,810−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −393,100−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −133,284−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −58,365−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −55,283−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −22,275−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −20,552−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |